CFTR gene analysis in patient with atypical cystic fibrosis
Author(s) -
Aleksandra Nikolić,
Aleksandra Divac Rankov,
Nada Bogdanović,
Marija Mitić-Milikić,
Dragica Radojković
Publication year - 2004
Publication title -
jugoslovenska medicinska biohemija
Language(s) - English
Resource type - Journals
eISSN - 1452-8193
pISSN - 0354-3447
DOI - 10.2298/jmh0404351n
Subject(s) - cystic fibrosis , sweat test , sweat , mutation , medicine , compound heterozygosity , heterozygote advantage , genetic testing , newborn screening , gene mutation , pathology , gene , genetics , genotype , biology , pediatrics
Summary: This paper reports a case of a patient presenting with atypical cystic fibrosis whose sweat test showes borderline values. In vast majority of cases the sweat test is essential diagnostic tool for establishing the diagnosis of cystic fibrosis, but only after the molecular genetic testing the diagnosis can be confirmed. The patient was found to be compound heterozygote for two CFTR mutations, F508del and D1152H. The presence of F508del mutation was analyzed by PSM method, while the screening for the second mutation was performed using DGGE. The strategy of mutation detection in cystic fibrosis patients, especially those with atypical presentations who carry less frequent mutations, should include both direct and indirect methods of molecular diagnostics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom